(Q54676894)
Statements
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy. (English)
Francesco Ria
Sergio Occhipinti
Michela Spadaro
Chiara Nicolò
Elena Ambrosino
Irene Fiore Merighi
Piero Musiani
Guido Forni
30 April 2010
184
11
6124-6132